Formulation Research Institute, Otsuka Pharmaceutical Co., Ltd.
Department of Chemical Engineering, Osaka Prefecture University.
Chem Pharm Bull (Tokyo). 2021;69(12):1184-1194. doi: 10.1248/cpb.c21-00665.
A quantitative evaluation method for determining the effect of tableting speed on the compression properties of pharmaceutical powders was investigated in this study. Cilostazol and ibuprofen were used as active pharmaceutical ingredients (APIs) and mixed with lactose monohydrate and microcrystalline cellulose. Viscoelasticity was examined to evaluate the raw material, and stress relaxation tests were conducted to determine the apparent viscosity and elasticity coefficients of the placebo and two APIs. Tablets were prepared using a compaction simulator and a rotary tablet press at the tableting speeds ranging from laboratory to commercial. The in-die or out-of-die strain rate sensitivity (SRS) indices were determined as a measure of the compressibility and compactibility. The results showed that the sensitivity of the out-of-die SRS was higher than that of the in-die SRS. The out-of-die SRS of ibuprofen 20% powder, which showed high elasticity and low viscosity, was 13.3-47.9%, whereas that of the placebo and cilostazol 20% (w/w) powder was <7.5%. A peripheral speed difference of more than 300 mm/s during the out-of-die SRS was sensitive enough to detect the capping tendency. Cilostazol, which has lower elasticity and higher viscosity than ibuprofen, was tested using powder mixtures with the API concentrations of 5-40%; the compressibility SRS was <5% for all API concentrations. In contrast, the compressibility SRS of ibuprofen increased from 4.8 to 81% depending on the API concentration. Using the compressibility SRS as an index, it was possible to extract the tableting speed-dependent compressibility characteristics of API from the powder mixtures containing API.
本研究旨在探索一种定量评价方法,用于确定压片速度对药物粉末压缩性能的影响。西洛他唑和布洛芬被用作活性药物成分(API),并与一水乳糖和微晶纤维素混合。通过考察粘弹性来评估原材料,并进行应力松弛试验来确定安慰剂和两种 API 的表观粘度和弹性系数。使用压片机和旋转压片机在从实验室到商业规模的压片速度范围内制备片剂。通过测定模内或模外应变率敏感性(SRS)指数来评估可压缩性和压缩性。结果表明,模外 SRS 的敏感性高于模内 SRS。弹性高、粘性低的布洛芬 20%粉末的模外 SRS 为 13.3-47.9%,而安慰剂和西洛他唑 20%(w/w)粉末的模外 SRS 则小于 7.5%。在模外 SRS 期间,外周速度差超过 300 mm/s 足以检测到顶裂倾向。西洛他唑的弹性低于布洛芬,粘性高于布洛芬,用 API 浓度为 5-40%的粉末混合物进行了测试;所有 API 浓度的可压缩性 SRS 均小于 5%。相比之下,布洛芬的可压缩性 SRS 随 API 浓度从 4.8%增加到 81%。使用可压缩性 SRS 作为指标,可以从含有 API 的粉末混合物中提取出 API 依赖于压片速度的压缩性能特征。